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Abstract
Pancreatic islets are heterogeneous clusters mainly composed of α and β cells, and
these clusters range in diameter from 50 to several hundred micrometers. Native
small islets are known to have a higher insulin secretion ability in vitro and to
provide better transplantation outcomes when compared with large islets. In this
study, we prepared microengineered pseudo-islets from dispersed rat islet cells
using precisely-fabricated agarose gel-based microwells with different diameters
(100, 300, or 500 μm) to investigate the function and survival of islet cell
aggregates with well-controlled sizes. We observed that dead cells were rarely
present in the small pseudo-islets with an average diameter of ∼60 μm prepared
using 100 μm microwells. In contrast, we observed more dead cells in the larger
pseudo-islets prepared using 300 and 500 μm microwells. The relative amount of
hypoxic cells was significantly low in the small pseudo-islets whereas a hypoxic
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condition was present in the core region of the larger pseudo-islets. In addition, we
found that the small-sized pseudo-islets reconstituted the in vivo-tissue like
arrangement of the α and β cells, and restored the high insulin secretory capacity in
response to high glucose. These results clearly suggest that precise size control of
pseudo-islets is essential for maintaining islet cell function and survival in vitro.
The small-sized pseudo-islets may be advantageous for providing a better
therapeutic approach for treating type 1 diabetes mellitus via islet reorganization
and transplantation.
Keywords: Medicine, Engineering, Bioengineering
1. Introduction
Type 1 diabetes is an autoimmune disease involving destruction of β cells in the
pancreatic islets of Langerhans. Type 1 diabetic patients need to take insulin by
injection for their entire life. Recently, pancreatic islet transplantation has been
developed as an alternative therapy to insulin injection for patients with severe
type 1 diabetes [1]. Islet transplantation is less invasive when compared to
transplanting the whole pancreas. Isolated islets are transplanted into the liver
through the portal vein in most cases, but the procedure requires a large amount of
islets, usually from multiple (2–3) donors for treating one patient. Additionally,
islet transplantations often need to be done multiple times to achieve insulin
independence, because of graft damage and cell loss in the pre- and post-transplant
period. Recently, a single-donor islet transplant has been reported [2, 3], but it is
possible only at selected facilities and thus, is not universally available for all
patients [4].
Another problem with the current islet transplantation therapy is that the long-term
outcomes of insulin independence are poor when compared with that of whole
pancreas transplantation. It was reported that about 70% of the patients transplanted
with islets using the original Edmonton Protocol maintained insulin independence
at 1 year post-transplantation, but it decreased to only 7.5% after 5 years [5]. More
recently, the rate of five-year insulin independence has improved with advanced
methods, but it is still only approximately 50% [6]. The current challenge of islet
transplantation is to provide long-term insulin independence using lower islet
masses from a single donor. From this viewpoint, an improvement in islet cell
function and survival is needed for developing more efficient pancreatic islet
transplantation.
It is well known that there is a size distribution of native islets in the pancreas
ranging from 50 to 500 μm [7, 8]. Many studies have suggested that there is a close
relationship between the size and function of the islets. In general, native small
islets are superior to large ones in terms of insulin secretion and cell survival both
in vivo and in vitro [8, 9, 10, 11]. For instance, native smaller rat islets released a
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larger amount of insulin in in vitro culture and were highly effective in achieving
euglycemia when compared with larger ones when they were transplanted into
diabetic rats [10].
Recently, various techniques have been proposed to artificially fabricate 3D
cellular aggregates that can mimic the microenvironments of in vivo tissues. One of
the most frequently employed strategies is the preparation of multicellular
spheroids/aggregates. Microfabricated non-cell-adhesive wells, hanging-drop, and
3-dimentional (3-D) suspension culture techniques have been used to make
aggregates of islet cells, hepatocytes, cancer cells, embryonic stem (ES) cells, and
induced pluripotent stem (iPS) cells [12, 13]. When cells (e.g., islet cells, β cell
line, etc.) are seeded in an environment with non-cell-adhesive surfaces, the cells
spontaneously aggregate to form spheroids [14, 15, 16, 17, 18, 19, 20, 21]. Using
the dispersed islet cells, attempts have been made to prepare islet cell aggregates
(pseudo-islets) that contain β cells with restored insulin secretion activity
comparable to that of native islets [14, 15, 16, 18]. In addition, pseudo-islets
incorporating adipose-derived stem cells were created to enhance insulin secretion
for a long period of time [21]. Microfabricated chambers allow us to form pseudo-
islets with precisely controlled sized, which is suitable to investigate the size effect
on the islet cell function and viability. For example, Sakai, et al. investigated the
effect of O2 tension and size on the function of β cell line (MIN-6 cells) aggregates
using oxygen-permeable PDMS chambers [20]. However, the effects of the size of
the re-assembled pseudo-islets from primary islet cells on the cell function and
morphology have not been investigated in detail. We hypothesized that if the islet
cells are re-assembled into pseudo-islets with an optimal size, the function and
survival of the islet cells would be enhanced. Such precisely microengineered
pseudo-islets would be advantageous when they are transplanted in vivo for
treating type 1 diabetics. In this study, we fabricated several types of non-cell-
adhesive hydrogel microwells with different diameters to prepare pseudo-islets
with well-controlled sizes from dispersed rat islet cells. We examined the size
effects of microengineered pseudo-islets on cell viability, distribution of hypoxic
cells, arrangement of α/β cells composing the pseudo-islets, and insulin secretion
ability of β cells in vitro, to demonstrate the usefulness and the potential
applicability of the size-controlled pseudo-islets.
2. Materials and methods
2.1. Isolation of rat islets and preparation of single cells
All animal studies were performed with the approval of the Institutional Animal
Care and Use Committee of Tokyo Women’s Medical University. Pancreatic islets
were isolated from 9–12 week-old male Lewis rats (Charles River Laboratories,
Yokohama, Japan) via collagenase digestion and density-gradient centrifugation
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using Histopaque solutions with different densities (1.119, 1.100, and 1.077 g/mL,
prepared from Histopaque 1119 and 1077, Sigma-Aldrich, St. Louis, MO) as
previously described [22]. After isolation, the islets were hand-picked under a
stereomicroscope and cultured in RPMI-1640 medium (Thermo Fisher Scientific,
Waltham, MA) supplemented with 10% fetal bovine serum (FBS), 5.5 mmol/L
glucose, 10 mmol/L HEPES, 1 mmol/L sodium pyruvate, 0.1 mmol/L nonessential
amino acids, 100 IU/mL penicillin, and 100 μg/mL streptomycin at 37 °C and 5%
CO2 overnight to recover the damage of islets by collagenase treatment [23]. Then,
the islets were digested using 0.25% Trypsin-EDTA (Thermo Fisher Scientific) to
obtain single cells as previously described [24] and re-suspended in the culture
medium at a concentration of 7.5 × 106 cells/mL. The viability of the dispersed
islet cells was approximately 90% right after trypsin/EDTA treatment. The
percentages of α and β just after islet digestion were 10.7 ± 3.2% and 78.2 ± 4.6%,
respectively, which were determined by immunohistochemistry (details are
described in "Double-immunohistochemistry for insulin and glucagon" section).
[(Fig._1)TD$FIG]
Fig. 1. The design of agarose gel-based microwells. (A) A micromold to fabricate an agarose gel-based
microwell plate. (B) Illustration of an agarose gel-based microwell plate. The distance between the
microwells was equal to that of the microwell diameter [D]. The depth [d] of the microwell was
approximately twice that of the diameter [D]. (C) Three different sizes of agarose gel-based plates with
diameters of 100, 300, and 500 μm microwells. The total areas of the microwells were almost equal in
three types of agarose gel-based microwell plates. There were 54 × 54, 18 × 18, and 11 × 11 microwells
for 100, 300, 500 μm plates, respectively. Scale bar = 5 mm.
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2.2. Fabrication of agarose gel-based microwells
The microwell design is shown in Fig. 1A–C. We employed three different sizes of
agarose gel-based microwells with diameters of 100, 300, and 500 μm. The
distance between the microwells was equal to the microwell diameter. The depth of
the microwell was approximately twice the length of the diameter. The total areas
of the microwells were almost the same in the three types of microwell plates.
There were 54 × 54, 18 × 18, and 11 × 11 microwells per 100, 300, and 500 μm
microwell plate, respectively. The micromolds for the agarose gel plates with
microwells were prepared using soft lithography, as described previously [25].
Briefly, cylindrical structures made of a negative photoresist (SU-8 3050, Nippon
Kayaku, Tokyo, Japan) were patterned on a silicon wafer with a size of
15 × 15 mm by photolithography and developed using ethyl lactate. The prepared
mold was placed in a 6-well plate. Seven mL of an aqueous 3% agarose (Agarose
L03, Takara Bio, Shiga, Japan) in saline, dissolved via heating, was poured into the
well. After cooling at room temperature for 1 h, the agarose gel plate was removed
from the molds, transferred to another 6-well culture plate, and equilibrated with
the cell culture medium for 15 min at room temperature. The medium was changed
twice within 1 h.
2.3. Formation of size-controlled pseudo-islets
Two hundred μL of the single cell suspension (7.5 × 106 cells/mL) was pipetted
onto the agarose gel plate with the microwells. The number of the seeded cells was
optimized so that microwells were filled with islet cells and the numbers of the
introduced cells for all the wells became constant. After cell seeding, the culture
plate was shaken gently for 5 min on a plate shaker to distribute the cells evenly
into the microwells, and then it was incubated at room temperature for 10 min.
Then, 2 mL of the culture medium was gently added to the culture plate. The cells
in the microwells were cultured at 37 °C in 5% CO2 for 7 days. As a control,
isolated intact islets were also cultured on an agarose gel plate without microwells.
2.4. Size measurement of microengineered pseudo-islets
Micrographs of islet cell aggregations were taken in 3–5 randomly selected fields
per a well using an inverted microscope at 7 days after cultivation. The size of the
aggregates was calculated from digital images using Image J software (National
Institutes of Health, Bethesda, MD) (n = 30 ∼ 105).
2.5. Assessment of cell viability in microengineered pseudo-islets
The cell survival and death of pseudo-islets were assessed by the LIVE/DEAD
Viability/Cytotoxicity Kit (Thermo Fisher Scientific) at 7 days after cultivation.
The aggregates were incubated in a mixture of 4 μM calcein AM (live cell, green)
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and 8 μM ethidium homodimer-1 (dead cell, red) for 45 min at room temperature.
The confocal image stacks of aggregates were acquired by a confocal laser-
scanning microscope (FLUOVIEW FV1200; Olympus, Tokyo, Japan). The ratio of
the red-colored area to the total cell area (%) was calculated from the confocal
images of the aggregates in 3–4 randomly selected fields per sample using Image J
software.
2.6. Detection of hypoxic cells
Hypoxic cells in the pseudo-islets were detected by a Hypoxyprobe-1 Kit
(Hypoxyprobe, Burlington, MA). After 7 days of cultivation, the aggregates in the
microwells were incubated for 2 h in the presence of 200 μM pimonidazole
hydrochloride (Hypoxyprobe-1). Then, the aggregates were collected, embedded in
iPGell (GenoStaff, Tokyo, Japan), and fixed with 4% paraformaldehyde (PFA) for
4 h according to the manufacturer's instructions. The gels containing aggregates
were embedded in paraffin and sectioned at 5 μm. The sections were incubated
with mouse monoclonal anti-pimonidazole antibody overnight at 4 °C. Alexa Fluor
488-conjugated goat anti-mouse IgG antibody (Thermo Fisher Scientific) was used
as the secondary antibody. The sections were mounted with ProLong Gold
Antifade Reagent with DAPI (Thermo Fisher Scientific). The images were taken
with a fluorescence microscope (Olympus BX51).
2.7. Double-immunohistochemistry for insulin and glucagon
After 7 days of cultivation, pseudo-islets were collected from microwells. Pseudo-
islets and intact islets (cultured for 0 or 7 days) were embedded in iPGell, and fixed
with 4% PFA. The fixed cells were embedded in paraffin and sectioned at 5 μm.
The sections were incubated with guinea-pig polyclonal anti-insulin antibody
(Abcam, Cambridge, UK) and with mouse monoclonal anti-glucagon antibody
(Abcam) overnight at 4 °C. For double-immunofluorescent staining, the sections
were treated with both Alexa Fluor 488-conjugated goat anti-guinea pig IgG and
Alexa Fluor 594-conjugated goat anti-mouse IgG (Thermo Fisher Scientific) for
30 min. The images were obtained with a fluorescence microscope. The numbers
of β cells (insulin-positive cells), α cells (glucagon-positive cells), and the total
cells (DAPI) were counted on the images obtained by immunohistochemistry for
each condition, and the percentage of each cell type was calculated.
2.8. Glucose-induced insulin secretion assay
After 7 days of cultivation, pseudo-islets were preincubated for 3 h at 37 °C with
the cell culture medium containing 3.3 mmol/L glucose. Subsequently, the cells
were incubated with fresh medium containing 3.3 mmol/L glucose for 1 h. Then,
the medium was replaced with medium containing 20 mmol/L glucose, and the
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cells were incubated for 1 h. At the end of each step, the medium was collected for
determination of the insulin level. The concentration of insulin in the medium was
measured by the Mercodia Rat Insulin ELISA Kit (Mercodia, Uppsala, Sweden)
according to the manufacturer's instructions. The relative cell viability of the islet
cells was determined by a WST-8 (water-soluble tetrazolium salt) assay using Cell
Count Reagent SF kit (Nacalai Tesque, Kyoto, Japan). In addition, the DNA
content of the pseudo-islets was determined by a DNA quantitation kit (Bio-Rad,
Hercules, CA). The values of insulin secretion were normalized to the absorbance
values from WST-8 assay or the DNA content in the islet cells.
2.9. Statistical analysis
All data are expressed as the mean ± standard deviation (SD). Significant
differences between the groups were tested using analysis of variance (ANOVA)
followed by a Tukey honestly significant difference (HSD) post-hoc test with IBM
SPSS Statistics 18 software (IBM Japan, Tokyo). A probability value less than 0.05
(P < 0.05) was considered to be statistically significant.
3. Results
3.1. Formation of size-controlled pseudo-islets using rat islet
cells
Islets were freshly isolated from Lewis rats, and then dispersed with trypsin/EDTA
into a suspension of single islet cells. To form aggregates of rat islet cells, a
suspension of the dispersed islet cells at a concentration of 7.5 × 106 cells/mL was
pipetted onto the agarose gel plates containing microwells of different sized
diameters (100, 300, or 500 μm). The numbers of the islet cells introduced into the
100, 300, and 500 μm microwells were estimated to be approximately 500, 4,600,
and 12,400 cells for each microwell, respectively. During cell cultivation, the
single islet cells spontaneously assembled into aggregates because of the non-cell-
adhesive nature of the agarose hydrogel, and islet-like round aggregates (pseudo-
islets) formed after several days of cultivation. The aggregate sizes in the
microwells varied depending on the well diameter, mainly because of the different
amounts of the inoculated cells per microwell. Fig. 2A shows the pseudo-islets
formed in the microwells at 1 and 7 days after cultivation. After 1 day of
cultivation, cells were loosely aggregated in the microwells. Fig. 2B shows the
time-course change of the pseudo-islet size in the microwells. Islet-like spherical
aggregates spontaneously formed in the microwells within 3 days. The size of the
pseudo-islets was smaller than that of the microwells, due to contraction among the
cells. After 7 days of cultivation, the average diameters ± SD of the pseudo-islets
in 100, 300, and 500 μm microwells were 49.5 ± 4.9 μm, 144.1 ± 13.7 μm, 222.8
± 16.6 μm, respectively, while the intact control islets were 174.9 ± 65.8 μm
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(Fig. 2B). The sizes of the intact islets were not significantly changed during
cultivation for 7 days, but the size distribution was larger. These results clearly
demonstrated the ability of the microfabricated microwell-based cultivation
technique for precisely controlling the size of the assembled 3D islet tissue-like
constructs.
3.2. Detection of both live/dead cells and hypoxic cells in the
microengineered pseudo-isles
To determine the live and dead cells in the formed pseudo-islets and the intact
islets, the aggregates comprising the islet cells were stained with calcein AM (live,
green) and ethidium homodimer-1 (EthD-1; dead, red) (Fig. 3A–D) or EthD-1
alone (Fig. 3E–H) at day 7. In the relatively large pseudo-islets prepared using
300 μm and 500 μm microwells (Fig. 3B, C, F, G) and the large-sized intact islets
(Fig. 3D, H), live cells localized at the periphery while cell death occurred mainly
in the central core region. In contrast, dead cells were rarely observed in the small
pseudo-islets prepared using the 100 μm microwells (Fig. 3A, E) and in the small-
sized intact islets (Fig. 3D, H). The ratios of red-stained area to total area (%),
[(Fig._2)TD$FIG]
Fig. 2. The formation of size-controlled pseudo-islets using agarose gel-based microwells. (A)
Dispersed rat islet cells were cultured in 100 μm, 300 μm, and 500 μm agarose-based microwells for 1
and 7 days. Intact islets were also cultured on an agarose gel plate without microwells as control. The
aggregate size increased with increasing diameter of the agarose-based microwell. Scale bar = 500 μm.
(B) The diameter of the pseudo-islets prepared using 100, 300, and 500 μm microwells and cultured
intact islets at 1, 3, and 7 days after cultivation. Data are presented as the mean ± SD (n = 30 ∼ 105).
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which are related to the ratios of dead cells, in the pseudo-islets prepared using
100, 300 and 500 μm microwells and in the intact islets were 0.11 ± 0.02%, 1.68 ±
0.82%, 11.26 ± 5.13%, and 3.66 ± 1.38%, respectively, indicating that the small
size resulted in significantly less cell death (Fig. 3I). We then determined the
presence of hypoxic cells in the pseudo-islets and intact islets using the
Hypoxyprobe-1 Kit at day 7 (Fig. 3J–M). As shown in Fig. 3J, the pseudo-islets
prepared using the 100 μm microwells had little or no hypoxic cells in the central
core region. However, the number of hypoxic cells increased in the core with the
increase in the aggregate size (Fig. 3 K, L), suggesting that the hypoxic condition
induced islet cell death in the pseudo-islets larger than 150 μm. In the pseudo-islets
prepared using 500 μm microwells, hypoxic cells were partially present in the
peripheral region, which possibly indicates that cells locating near the bottom of
[(Fig._3)TD$FIG]
Fig. 3. Detection of cell death and hypoxic cells in size-controlled pseudo-islets. (A–H) Confocal
images of (A–D) live/dead staining and (E–H) dead staining alone of pseudo-islets prepared using (A,
E) 100 μm, (B, F) 300 μm, and (C, G) 500 μm microwells and (D, H) intact islets (control) at day 7.
Aggregates were stained with calcein AM (live cell, green) and with ethidium homodimer-1 (dead cell,
red). (I) The level of cell death in the pseudo-islets prepared using 100, 300, and 500 μmmicrowells and
intact islets (control). The ratio of red stained area to total area of aggregates (%) was calculated from
3–4 randomly selected fields/sample using Image J software. Data are presented as the mean ± SD.
*Significant differences between groups (p < 0.05). (J–M) Immunostaining for hypoxyprobe
(pimonidazole) in cross-sections of pseudo-islets prepared using (J) 100 μm, (K) 300 μm, and (L)
500 μm microwells and (M) intact islets (control). Aggregates were incubated in the presence of
200 μM pimonidazole hydrochloride to detect hypoxic cells in aggregates at 7 days after cultivation.
Arrows shows hypoxyprobe-positive cells. Scale bars = 200 μm.
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the microwell were in a hypoxic condition because of the limited oxygen supply. In
the relatively large-sized intact islets, hypoxic cells were observed near the center
(Fig. 3 M).
3.3. Localization of α cells and β cells in the microengineered
pseudo-islets
In rodent islets, the insulin producing β cells localize in the central area of islets,
while the glucagon producing α cells localize at the periphery, surrounding the β
cells [26], as shown in Fig. 4A. We investigated the arrangement of the α and β
cells in the reconstituted pseudo-islets by immunohistochemistry (Fig. 4). After 7
days of cultivation, the insulin- and glucagon-positive cells were observed in the
[(Fig._4)TD$FIG]
Fig. 4. Cell arrangement and composition of microengineered pseudo-islets and intact islets. (A–F)
Immunohistochemisty for insulin (green) and glucagon (red) in cross-sections of intact islets at (A) day
0 and (B, C) day 7 (control) and pseudo-islets prepared using (D) 100 μm, (E) 300 μm, and (F) 500 μm
microwells at 7 days after cultivation. Scale bar = 200 μm. (G) The ratio of α and β cells in the intact
islets prior to dissociation (control) at day 0, pseudo-islets prepared using 100 μm, 300 μm, and 500 μm
microwells at day 7, and cultured intact islets (control) at day 7. The numbers of β cells (insulin positive
cells), α cells (glucagon positive cells), and total cells (DAPI) were counted on the images obtained by
immunohistochemistry (n = 18 ∼ 22).
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pseudo-islets prepared using 100, 300, and 500 μm microwells (Fig. 4D–F). In the
pseudo-islets prepared using 100 and 300 μm microwells, insulin- and glucagon-
positive cells were distributed in the central area and in the periphery, respectively
(Fig. 4D, E). This characteristic cellular arrangement is morphologically similar to
that observed in the relatively small native islets at day 0 and 7 (Fig. 4A, B). In
contrast, several glucagon-positive cells were located in the core region of the large
pseudo-islets prepared using the 500 μm microwells, as in the case of the large-
sized intact islets at day 7 (Fig. 4C, F). These data suggest that adequate
reconstitution of islet-like arrangement of islet cells was induced in both small and
medium pseudo-islets prepared using 100 and 300 μm microwells. Fig. 4G shows
the ratio of α and β cells composing the pseudo-islets and native islets. There was
no significant difference in the cellular compositions of α and β cells between
pseudo-islets prepared using three types of microwells at day 7, while the ratios of
α cells in pseudo-islets were slightly higher compared to that of the intact islets at
day 0.
3.4. Insulin secretory capacity of size-controlled pseudo-islets
We next sought to assess the functional capacity of the pseudo-islets. After 7 and
14 days of cultivation, pseudo-islets prepared using 100, 300, and 500 μm
microwells and cultured intact control islets were exposed to media containing
basal glucose (3.3 mM), and then the cultures were exposed to media containing
high glucose (20 mM). The concentrations of insulin secreted into the culture
media with basal/high glucose levels normalized to DNA content are shown in
Fig. 5A, B. In addition, the insulin secretions normalized to the cell metabolic
activity based on WST-8 assay are shown in Fig. 5C, D. At day 7, insulin secretion
was stimulated by exposure to a high glucose medium, showing that the insulin
secretory responsiveness of the islet cells composing the pseudo-islets was
preserved (Fig. 5A, C). Notably, the insulin release from the pseudo-islets prepared
using the 100 μm microwells at the high glucose level was significantly higher than
that secreted by the pseudo-islets prepared in the 300 and 500 μm microwells and
intact islets. This result indicates that small pseudo-islets had a much greater ability
to secrete insulin in response to glucose stimulation, likely due to the high surface-
to-volume ratio and the short diffusion distance for efficiently supplying oxygen
and nutrition. At day 14, the insulin secretion levels of the pseudo-islets were
decreased in all conditions using different-sized microwells (Fig. 5B, D). There
was no statistical difference between groups of pseudo-islets. The insulin secretion
level of the intact islets was also decreased compared to that at day 7, but its
decrease rate was slightly suppressed compared to those of pseudo-islets. This
result indicates that the remaining ECM components in the intact islets might have
contributed to the maintenance of β cell function and islet cell survival, as
described in a previous study [27]. Further optimization of the cultured conditions
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will be possible, such as incorporation of ECM components [25] into the pseudo-
islets.
4. Discussion
Sufficient oxygen and nutrients are supplied by the blood circulation to pancreatic
islets in vivo, which is indispensable to both the survival and hormone secretion of
islet cells. It was previously reported that in the presence of high glucose insulin
secretion by mouse insulinoma βTC3 cells at a partial oxygen tension (pO2) less
than 7 mmHg was significantly lower than that at a higher pO2 [28]. In addition,
the pO2 is decreased with distance from a blood vessel in in vivo tissues. The pO2
level was less than 10 mmHg at a distance of 50 μm from a vessel wall in the
arterioles in the rat mesentery [29]. In the case of islets isolated from the body via
collagenase perfusion, the microcirculation through the islet tissue is no longer
[(Fig._5)TD$FIG]
Fig. 5. Glucose stimulated insulin secretion from pseudo-islets and intact islets. (A–D) Pseudo-islets
formed in 100 μm, 300 μm, and 500 μm microwells (n = 6) and cultured intact islets (control; n = 6)
were incubated with 3.3 mmol/L glucose and subsequently 20 mmol/L glucose at (A, C) day 7 and (B,
D) day 14. Insulin concentration was normalized to (A, B) the DNA content in the islet cells or (C, D)
the absorbance values from WST-8 assay. Data are presented as the mean ± SD. *Significant
differences between groups (p < 0.05).
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present. Therefore, oxygen and nutrients are supplied to the isolated/transplanted
islets only by diffusion from the culture medium and from the surrounding tissues,
respectively. The absence of a circulation within islets leads to an insufficient
supply of oxygen and nutrients, especially for cells in the core region of large islets
(> 100 μm). In fact, the pO2 level in the transplanted islet grafts was extremely low
(∼5 mmHg) compared with that in the in vivo islets (∼40 mmHg) regardless of the
transplantation site (kidney, liver, and spleen) [30], because of the insufficient
revascularization within the islet grafts. It is therefore logical that the superiority of
small islets is primarily due to the short diffusion distance. Researchers
demonstrated that native small islets isolated from the pancreas are superior to
large ones when either cultured in vitro or transplanted in vivo [8, 9, 10, 11]. The
superiority of the native small islets has also been studied at the molecular level. A
previous study reported that the expression of angiotensinogen was significantly
low but that of VEGF-A was high in small islet grafts, indicating the improved
microcirculation and enhanced revascularization in the transplanted small islets,
respectively [9].
Selection of native small islets from isolated islets for transplantation therapy of
type 1 diabetes is not practical, due to the worldwide shortage of pancreas/islet
donors. The islet cells dispersed by trypsinization have an ability to reconstitute
aggregates, and the reorganized pseudo-islets retain the ability to secrete insulin at
levels comparable to that of native islets [14]. Hence, we hypothesized that a better
therapeutic approach for transplantation can be realized if islets of various sizes are
dispersed as single cells and then reorganized into small islet-like aggregates with
both a higher function and longer survival. However, conventional culture methods
were not able to precisely control the size of the pseudo-islets.
Recently, tissue engineering techniques have been newly developed to fabricate
functional micro-tissues using cells and biochemical materials. Islet cell sheets for
transplantation were created using thermo-responsive culture dishes coated with
laminin-5 [24, 31]. Engineered pseudo-islets have also been prepared using either
precisely fabricated agarose-gel microwells [32, 33] or alginate hydrogel beads
[34]. However, to date, preparation of aggregates of islet cells with a well-
controlled size and their characterization have not been accomplished. In this
study, we employed precisely fabricated agarose hydrogel microwell platforms to
prepare size-controlled pseudo-islets from rat islet cells. Agarose microwells with
different diameters enabled us to create reliable aggregates of different sizes, when
the amounts of inoculated cells were controlled.
Another important finding in the present study is that a physiological cellular
organization of the α and β cells occurred in both the small and medium pseudo-
islets prepared using 100 and 300 μm microwells, respectively. This morphology
was less reconstituted in the large-sized pseudo-islets prepared using 500 μm
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microwells. In vivo-like organization of the islet cells (α and β cells) in pseudo-
islets has been previously reported both in vitro [14, 15, 16] and in vivo [35, 36],
but the in vivo-like cellular arrangement of islet cells in 3D culture platforms with
precisely controlled sizes has not been reported, and the size effect on the micro-
tissue organization was not fully investigated. Our findings clearly showed that the
cellular organization of both the α and β cells is closely associated with the pseudo-
islet size, suggesting that the aggregation process also requires a supply of oxygen
and nutrients in the pseudo-islets.
Recently, some research groups have succeeded in achieving reversal of
hyperglycemia by transplanting ES or iPS cell-derived β-like cells in diabetic
mice [37, 38, 39]. In these studies, the unprocessed stem cell-derived β-like cells
were used for transplantation. We expect that transplantation of 3D engineered
islet-like tissues with an appropriate size and composed of stem cell-derived
multiple types of cells (α and β cells) may have the potential to provide a more
efficient therapeutic approach for treating type 1 diabetes when compared to that
with transplantation of dispersed cells.
In summary, the present study demonstrated the close relationship between the size
and various cellular characteristics, including cell viability and functions, in the
microengineered pseudo-islets. The results clearly showed that the reconstituted
small pseudo-islets (45–55 μm) have a higher insulin secretion ability and
significantly less cell death than those of the medium (130–160 μm) and large
(200–240 μm) ones. In vivo-like cellular organization was promoted in both the
small and medium pseudo-islets. The presented approach for re-organizing islet
cells into the pseudo-islets with appropriate sizes using microfabricated well
structures will be highly useful and effective not only for transplantation therapy
but also for studying the cellular physiology of islets cells in in vivo tissue-like
microenvironments.
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